loading page

Rectal ulcer in a hemodialysis patient receiving Sodium Polystyrene sulfonate ( Sodium Kayexalate®)
  • +4
  • Julia Collot,
  • Mohammed Salaouatchi,
  • Fabienne Rickaert,
  • Albino Floriani,
  • Benoit Buysschaert,
  • Maria Mesquita,
  • Eric Godon
Julia Collot
Centre Hospitalier Regional de Huy
Author Profile
Mohammed Salaouatchi
CHU Brugmann - Site Victor Horta
Author Profile
Fabienne Rickaert
CHU de Liège
Author Profile
Albino Floriani
Centre Hospitalier Regional de Huy
Author Profile
Benoit Buysschaert
Centre Hospitalier Regional de Huy
Author Profile
Maria Mesquita
CHU Brugmann - Site Victor Horta
Author Profile
Eric Godon
Centre Hospitalier Regional de Huy
Author Profile

Abstract

Kayexalate® is associated with gastrointestinal injury that can be fatal. Physicians must be aware of the adverse events when prescribing this therapy. Clinical data and medication history should follow the biopsy material given to the pathologist, who will look for Kayexalate® crystals. Pathologists and physicians should work hand in hand.

Peer review status:ACCEPTED

12 Dec 2020Submitted to Clinical Case Reports
16 Dec 2020Submission Checks Completed
16 Dec 2020Assigned to Editor
30 Dec 2020Reviewer(s) Assigned
25 Jan 2021Review(s) Completed, Editorial Evaluation Pending
25 Jan 2021Editorial Decision: Revise Minor
19 Feb 20211st Revision Received
22 Feb 2021Submission Checks Completed
22 Feb 2021Assigned to Editor
22 Feb 2021Review(s) Completed, Editorial Evaluation Pending
01 Mar 2021Editorial Decision: Accept